Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Endocrinology|February 21, 2004
Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetesLing Fu, Linu M John, Sean H Adams, et al.
The Journal of Clinical Investigation|April 22, 2009
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in miceJing Qing, Xiangnan Du, Yongmei Chen, et al.
Blood|March 22, 2007
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphomaAndrew G Polson, Shang-Fan Yu, Kristi Elkins, et al.
Genes & Development|May 3, 2014
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growthAdam S Adler, Mark L McCleland, Sharon Yee, et al.
Cancer Cell|October 22, 2011
A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodiesGabriele Schaefer, Lauric Haber, Lisa M Crocker, et al.
Molecular Cancer Therapeutics|September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptakeYonglei Shang, Yifan Mao, Jennifer Batson, et al.
Cell|April 8, 2010
PlGF blockade does not inhibit angiogenesis during primary tumor growthCarlos Bais, Xiumin Wu, Jenny Yao, et al.
Cancer Cell|August 8, 2017
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug ExposureGulfem Dilek Guler, Charles Albert Tindell, Robert Pitti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2013
Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapiesMatthew J Brauer, Guanglei Zhuang, Maike Schmidt, et al.
Cancer Research|March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selectionAndrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Pageof 5